About

Publications While At HealthPartners

selected publications

Journal Article

Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. 

International Journal of Radiation Oncology, Biology, Physics. 2020

Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. 

Neuro-Oncology. 2020

Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. 

Journal of Clinical Oncology. 2020

Estimating survival in patients with gastrointestinal cancers and brain metastases: an update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)

2019

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG). 

Journal of Neuro-Oncology. 2019

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?. 

Translational Research: The Journal of Laboratory and Clinical Medicine. 2019

Effect of targeted therapies on prognostic factors, patterns of care, and survival in patients with renal cell carcinoma and brain metastases. 

International Journal of Radiation Oncology, Biology, Physics. 2018

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. 

Neuro-Oncology. 2018

Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (melanoma-molGPA). 

International Journal of Radiation Oncology, Biology, Physics. 2017

Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA). 

JAMA oncology. 2017

The prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases. 

International Journal of Radiation Oncology, Biology, Physics. 2017

The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases. 

International Journal of Radiation Oncology, Biology, Physics. 2016

Editorial Article

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation [editorial]. 

Lancet Oncology.  19. 2018

Contact

full name

P. D. Brown

Quick Info

 

Collaboration

Co-author network

Map of science